ATE480233T1 - Zusammensetzungen mit polysacchariden - Google Patents

Zusammensetzungen mit polysacchariden

Info

Publication number
ATE480233T1
ATE480233T1 AT06723040T AT06723040T ATE480233T1 AT E480233 T1 ATE480233 T1 AT E480233T1 AT 06723040 T AT06723040 T AT 06723040T AT 06723040 T AT06723040 T AT 06723040T AT E480233 T1 ATE480233 T1 AT E480233T1
Authority
AT
Austria
Prior art keywords
component
compositions
disclosure
isoflavone
isoflavones
Prior art date
Application number
AT06723040T
Other languages
English (en)
Inventor
Chyi-Cheng Chen
Bruno Leuenberger
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Application granted granted Critical
Publication of ATE480233T1 publication Critical patent/ATE480233T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Reproductive Health (AREA)
AT06723040T 2005-02-15 2006-02-14 Zusammensetzungen mit polysacchariden ATE480233T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05003166 2005-02-15
PCT/EP2006/001331 WO2006087164A1 (en) 2005-02-15 2006-02-14 Compositions containing polysaccharides

Publications (1)

Publication Number Publication Date
ATE480233T1 true ATE480233T1 (de) 2010-09-15

Family

ID=34933756

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06723040T ATE480233T1 (de) 2005-02-15 2006-02-14 Zusammensetzungen mit polysacchariden

Country Status (9)

Country Link
US (1) US9579303B2 (de)
EP (1) EP1853252B1 (de)
JP (1) JP5566008B2 (de)
KR (1) KR101359859B1 (de)
CN (1) CN101119720B (de)
AT (1) ATE480233T1 (de)
DE (1) DE602006016741D1 (de)
ES (1) ES2351257T3 (de)
WO (1) WO2006087164A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008104383A (ja) * 2006-10-24 2008-05-08 Toyo Hakko:Kk ダイエット用食品組成物
WO2009056212A1 (en) * 2007-10-29 2009-05-07 Dsm Ip Assets B.V. Compositions containing resveratrol and pectin
KR20110106355A (ko) * 2008-12-11 2011-09-28 악센투아 파마슈투칼스 아베 제니스테인의 결정성 형태
CN109043540A (zh) * 2018-10-16 2018-12-21 中国计量大学 提高黄酮提取物生物可及性的方法、黄酮组合物及含黄酮提取物的产品

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6414091A (nl) 1964-12-04 1966-06-06 Organon Nv Werkwijze voor het vloeibaar maken van poeders alsmede de aldus verkregen poeders
DE69333624T2 (de) * 1992-05-19 2005-09-15 Novogen Research Pty. Ltd., North Ryde Verwendung von isoflavon phyto-östrogen extrakten von soja oder klee
JPH1121246A (ja) 1997-07-03 1999-01-26 Fuji Oil Co Ltd 抗皮膚癌剤及び食品
NL1006602C2 (nl) 1997-07-16 1999-01-19 Cooperatie Cosun U A Nieuw pectine.
JPH1149694A (ja) 1997-08-04 1999-02-23 Fuji Oil Co Ltd 抗肝臓癌剤及び食品
EP0943242A1 (de) * 1998-02-26 1999-09-22 Puratos N.V. Granuliertes Brotvergesserungmittel sowie ihre Verwendung zur Herstellung von Teigwaren
JP3231276B2 (ja) 1998-04-17 2001-11-19 株式会社ファンケル キトサン組成物およびその製造方法
US6413546B1 (en) * 1999-03-18 2002-07-02 Indena, S.P.A. Tablets incorporating isoflavone plant extracts and methods of manufacturing them
US6544566B1 (en) * 1999-04-23 2003-04-08 Protein Technologies International, Inc. Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol
US6143337A (en) 1999-04-30 2000-11-07 The United States Of America As Represented By The Secretary Of Agriculture Extraction of pectin by microwave heating under pressure
US6375994B1 (en) 1999-08-20 2002-04-23 Sun Ten Laboratories, Inc. Preparation of fiber, L-glutamine and a soy derivative for the purpose of enhancement of isoflavone bioavailability
ATE250415T1 (de) 1999-12-22 2003-10-15 Hoffmann La Roche Arzneizusammensetzung enthaltend ascorbinsäure und pektin
WO2002074308A1 (en) 2001-03-15 2002-09-26 Roche Vitamins Ag Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids
CN1325049C (zh) 2001-07-30 2007-07-11 Dsmip资产有限公司 含有表没食子儿茶素没食子酸酯的组合物
US20050008692A1 (en) 2001-09-03 2005-01-13 Chyi-Cheng Chen Compositions comprising pectin and ascorbic acid
US20030059514A1 (en) 2001-09-10 2003-03-27 Villagran Francisco Valentino Compositions comprising soy protein and processes of their preparation
US20030175345A1 (en) 2001-12-06 2003-09-18 Hite Michael P. Isoflavone composition for oral delivery
CA2483545A1 (en) 2002-05-02 2003-11-13 Volker Kuellmer Coated, agglomerated phytochemicals
US7326797B2 (en) 2002-07-23 2008-02-05 Dsm Ip Assets B.V. Manufacture of isoflavones
CN1293068C (zh) * 2002-09-28 2007-01-03 胡传璞 一种具有保健功能的大豆提取物、其制造方法和其用途
KR100520408B1 (ko) * 2003-03-25 2005-10-10 주식회사 태평양 비만개선용 조성물

Also Published As

Publication number Publication date
JP5566008B2 (ja) 2014-08-06
WO2006087164A1 (en) 2006-08-24
EP1853252A1 (de) 2007-11-14
KR101359859B1 (ko) 2014-02-06
JP2008530160A (ja) 2008-08-07
KR20070102712A (ko) 2007-10-19
US9579303B2 (en) 2017-02-28
CN101119720A (zh) 2008-02-06
CN101119720B (zh) 2013-01-23
DE602006016741D1 (de) 2010-10-21
US20080193575A1 (en) 2008-08-14
ES2351257T3 (es) 2011-02-02
EP1853252B1 (de) 2010-09-08

Similar Documents

Publication Publication Date Title
HRP20050710A2 (en) Substituted n-arylheterocycles, method for production and use thereof as medicaments
MY143565A (en) Novel fluorocglycoside derivatives of pyrazoles: medicaments containing these compounds, and the use thereof
HRP20050532A2 (en) Novel fluoroglycoside heterocyclic derivatives, pharmaceutical products containing said compounds and the use thereof
HRP20050531B1 (hr) Novi aromatski derivati fluorglikozida, lijek koji sadrži te spojeve i njihova upotreba
MY137039A (en) Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
BR0312549A (pt) Derivados de indolin-fenilsulfonamida
IL163831A (en) Derivatives of aminoindazoles, pharmaceutical compositions comprising them, process for their preparation and use thereof
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
NO20074441L (no) 1-benzylindol-2-karboksamidderivater
IL184872A0 (en) Pyrazole derivatives, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments for treatment and prevention of cancers
IL185063A0 (en) Pyrazole derivatives, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments for treatment and prevention of cancers
TNSN08326A1 (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
NO20085338L (no) Substituerte 1,3-difenylpropanderivater, sammensetninger og anvendelser derav
CY1110926T1 (el) Υποκατεστημενες πυραζολο πυριδινες, συνθεσεις που τις περιεχουν, διαδικασια παρασκευης και χρηση
WO2008087367A3 (fr) Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations
MY147268A (en) Ketomethionine ketals and their derivatives
WO2006114520A3 (fr) Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
ATE520396T1 (de) Isoflavon-nanoteilchen und ihre verwendung
TW200800946A (en) Substituted piperazines as metabotropic glutamate receptor antagonists
GB9809349D0 (en) Heterocyclic derivatives
ATE480233T1 (de) Zusammensetzungen mit polysacchariden
TW200726758A (en) New pyridine analogues
UA94080C2 (ru) Ациклически-замещенные производные фуропиримидина и их применение для лечения сердечно-сосудистых заболеваний
SE0300457D0 (sv) Novel compounds
DE60306138D1 (de) Azaindolylpiperidinderivate als antihistaminika und antiallergika

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties